Functional Analysis of the Borrelia burgdorferi bba64 Gene Product in Murine Infection via Tick Infestation

• Toni G. Patton,

  Affiliation Microbiology and Pathogenesis Activity, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America

  ⨯
• Gabrielle Dietrich,

  Affiliation Tick-Borne Diseases Activity, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America

  ⨯
• Marc C. Dolan,

  Affiliation Tick-Borne Diseases Activity, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America

  ⨯
• Joseph Piesman,

  Affiliation Tick-Borne Diseases Activity, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America

  ⨯
• James A. Carroll,

  Affiliation Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America

  ⨯
• Robert D. Gilmore Jr.

  * E-mail: rbg9@cdc.gov

  Affiliation Microbiology and Pathogenesis Activity, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America

  ⨯